Immunocore Holdings plc

Historical 13F Holders

Symbol
IMCR
CUSIP
45258D105
All holders as of
Q2 2026
Type
Equity
Class
ADS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 45258D105 since 12/18/2024, newest first.

Filer % of Class Filed
FMR LLC 13G/A Amendment 2
3.6% 10/7/2026
Event 9/30/2026
Vestal Point Capital, LP 13G/A Amendment 1
3.5% 8/14/2026
Event 6/30/2026
Wellington Management Group LLP 13G/A Amendment 6
11.6% 8/13/2026
Event 6/30/2026
FMR LLC 13G/A Amendment 1
8.8% 8/6/2026
Event 6/30/2026
T. Rowe Price Investment Management, Inc. 13G/A Amendment 5 3.7% 5/15/2026
Event 3/31/2026
Vestal Point Capital, LP 13G
5.5% 5/15/2026
Event 3/31/2026
T. Rowe Price Investment Management, Inc. 13G/A Amendment 4 6.0% 3/6/2026
Event 2/28/2026
T. Rowe Price Investment Management, Inc. 13G/A Amendment 3 11.8% 2/17/2026
Event 12/31/2025
Bellevue Group AG 13G
5.6% 11/14/2025
Event 8/20/2025
Tang Capital Management LLC 13G
5.2% 10/24/2025
Event 10/17/2025
Primecap Management Co/CA/ 13G/A Amendment 1 7.5% 8/14/2025
Event 6/30/2025
Wellington Management Group LLP 13G/A Amendment 5
10.2% 8/5/2025
Event 7/31/2025
Wellington Management Group LLP 13G/A Amendment 4
9.1% 8/5/2025
Event 6/30/2025
T. Rowe Price Investment Management, Inc. 13G/A Amendment 2 14.1% 5/14/2025
Event 3/31/2025
Wellington Management Group LLP 13G/A Amendment 3
13.0% 5/12/2025
Event 3/31/2025
Jallal Bahija 13G 8.2% 2/14/2025
Event 12/31/2024
Primecap Management Co/CA/ 13G 5.3% 2/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 9.01 k $273 k
2026 Q2 145 52.4 M $1.66 B
2026 Q1 154 52.5 M $1.58 B
2025 Q4 160 52.4 M $1.82 B
2025 Q3 145 49.8 M $1.79 B
2025 Q2 147 48.4 M $1.50 B
2025 Q1 128 47.9 M $1.40 B
2024 Q4 125 46.0 M $1.34 B
2024 Q3 144 45.3 M $1.41 B
2024 Q2 157 44.1 M $1.50 B
2024 Q1 169 42.8 M $2.78 B
2023 Q4 154 38.7 M $2.64 B
2023 Q3 135 36.9 M $1.92 B
2023 Q2 131 35.3 M $2.12 B
2023 Q1 119 32.7 M $1.61 B
2022 Q4 116 30.3 M $1.73 B
2022 Q3 93 26.5 M $1.25 B
2022 Q2 74 21.0 M $785 M
2022 Q1 60 19.8 M $591 M
2021 Q4 51 18.1 M $655 M
2021 Q3 48 16.7 M $617 M
2021 Q2 48 14.8 M $577 M
2021 Q1 43 14.5 M $615 M